POTENZA THERAPEUTICS, INC.

Profile

Company Names

POTENZA THERAPEUTICS, INC.

Addresses

1030 MASSSACHUSETTS AVENUE, SUITE 210, CAMBRIDGE, MA 02138

1030 MASSACHUSETTS AVENUE, SUITE 210, CAMBRIDGE, MA 02138

C/O MPM CAPITAL, 200 CLARENDON STREET, 54TH FLOOR, BOSTON, MA 02116

Phone Numbers

617-425-9215
617-588-4150

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$35,000,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2017-12-19 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2014-12-02 
$30,000,000.00 
$38,000,000.00 
$8,000,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAKAE 
 
ASANUMA 
DIRECTOR
MITOKYNE, INC.   |  POTENZA THERAPEUTICS, INC.   |  AXIAL BIOTHERAPEUTICS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  DREN BIO, INC.   |  AXIAL THERAPEUTICS, INC.   |  NORMUNITY HOLDING COMPANY, LLC   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  CROSSBOW THERAPEUTICS, INC.
DAVID 
 
CORDO 
EXECUTIVE OFFICER
METAMARK GENETICS, INC.   |  MITOKYNE, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  TRIEZA THERAPEUTICS, INC.   |  RIBON THERAPEUTICS, INC.   |  ALLY THERAPEUTICS, INC.   |  WEREWOLF THERAPEUTICS, INC.
LUKE 
 
EVNIN 
DIRECTOR
ENTEROMEDICS INC   |  MPM BIOVENTURES V, L.P.   |  COSTIM PHARMACEUTICALS INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  ONCORUS, INC.   |  BLADE THERAPEUTICS, INC.   |  DIGITX PARTNERS LLC   |  TRIEZA THERAPEUTICS, INC.   |  MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  FRONTIER MEDICINES CORP   |  WEREWOLF THERAPEUTICS, INC.   |  UMOJA BIOPHARMA, INC.   |  REDONA THERAPEUTICS, INC.
PHIL 
 
GUTRY 
DIRECTOR
AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  CERECOR INC.
DANIEL 
 
HICKLIN 
EXECUTIVE OFFICER, DIRECTOR
POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  TRIEZA THERAPEUTICS, INC.   |  WEREWOLF THERAPEUTICS, INC.
REID 
 
LEONARD 
EXECUTIVE OFFICER
POTENZA THERAPEUTICS, INC.
SHUNICHIRO 
 
MATSUMOTO 
DIRECTOR
POTENZA THERAPEUTICS, INC.
ARNOLD 
 
ORONSKY 
DIRECTOR
APPLIED GENETIC TECHNOLOGIES CORP   |  ARCION THEREAPEUTICS INC   |  DRAIS PHARMACEUTICALS INC   |  ARCION THERAPEUTICS, INC.   |  USDS, INC.   |  MACROGENICS INC   |  TESARO, INC.   |  TELSAR PHARMA, INC.   |  SELDAR PHARMA, INC.   |  INTEGRATED DIAGNOSTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  PMV PHARMACEUTICALS, INC.   |  CENTREXION THERAPEUTICS CORP
CYNTHIA 
 
SEIDEL-DUGAN 
EXECUTIVE OFFICER
POTENZA THERAPEUTICS, INC.
JAMES 
 
WESCOTT 
EXECUTIVE OFFICER
POTENZA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-12-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-19 
2016-03-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-12-02 
2014-12-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-12-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#